autotaxin inhibitors (Merck Serono)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameautotaxin inhibitors (Merck Serono)
Drug Alias NameMSC-2207596
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEctonucleotide pyrophosphatase/phosphodiesterase 2 inhibitors
TargetsEctonucleotide pyrophosphatase/phosphodiesterase 2
Therapy Area/IndicationsImmune System DiseasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMerck Serono Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck Serono Sa
Active IndicationsN/A
Inactive IndicationsImmune System DiseasesNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A